The goal of the Vanderbilt Breast Cancer Adjuvant Therapy cohort study (NCT00954564) is to help breast cancer survivors. The study is designed to measure:
among postmenopausal women with breast cancer, but we also need women who have been through menopause but not been diagnosed with breast cancer.
Women who have been diagnosed with breast cancer OR who have not been diagnosed with breast cancer who are interested in finding out more should contact the study at 1-800-811-8480 (toll free).
We aim to improve quality of life, adherence, and survival in women with breast cancer. Women will be asked to complete surveys or interviews and may be asked to use a special medication tracking cap and/or allow for the collection of biologic specimens (optional).
Funding and scientific collaboration for this study provided by: The American Cancer Society (119475-MRSG-10-169-01-PCSM), Vanderbilt Institute for Clinical and Translational Research (Vanderbilt CTSA grant UL1 RR024975 from NCRR/NIH), Vanderbilt Women's Health Research (5K12HD043483-09), Vanderbilt Ingram Cancer Center, Vanderbilt Internal Medicine, Vanderbilt Institute for Medicine and Public Health, Vanderbilt Division of Rheumatology and Immunology, Vanderbilt Epidemiology Center, Vanderbilt REACH for Survivorship, Northwestern University, University of Texas Southwestern Medical Center, and the National Institutes of Health (NICHD, NCI, NCMHD).